StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $63 at Jefferies
March 5, 2025 5:21 AM
Jefferies analyst Amy Li lowered the price target on Biohaven Pharmaceutical Holding (NYSE: BHVN) to $63.00 (from $64.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
TD Cowen on Biohaven Pharmaceutical Holding (BHVN): 'BHV-1300 Is Crushing Its Target'
March 4, 2025 10:39 AM
RBC on Biohaven Pharmaceutical Holding (BHVN): 'Stock Reaction Overdone On Bipolar Miss'
March 4, 2025 10:26 AM
Bernstein: 'Still like Biohaven Pharmaceutical Holding (BHVN) Stock but No Longer a Top Pick'; PT Lowered
March 4, 2025 6:52 AM
Form 8-K Biohaven Ltd. For: Mar 03
March 3, 2025 4:26 PM
Form 10-K Biohaven Ltd. For: Dec 31
March 3, 2025 4:26 PM
Biohaven Pharma (BHVN) Misses Q4 EPS by 11c
March 3, 2025 4:25 PM
Piper Sandler Reiterates Overweight Rating on Biohaven Pharmaceutical Holding (BHVN)
March 3, 2025 12:35 PM
Biohaven Pharma (BHVN) Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300
March 3, 2025 7:31 AM
Biohaven Reports Positive Degrader Data Achieving > 80% Sustained Reductions in Total IgG with Potential First-in-Class BHV-1300
March 3, 2025 7:31 AM
Biohaven Reports Recent Business Developments and Fourth Quarter and Full Year 2024 Financial Results
March 3, 2025 7:30 AM
